From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Stimwave announces first patient in Brazil
Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief device treatment for chronic pain. The patients are expected to receive the neuromodulation treatment as an alternative to opioid pain relief. The devices created by Stimwave deliver small pulses of energy to specific nerves to trigger a reaction that allows the brain to remap pain.
2. Nemaura touts uplisting to OTCQB
Nemaura Medical recently uplifted to the OTC Quote Board Venture Market trading platform, according to a July 10 press release. The company’s focus is on developing and commercializing a wireless disposable adhesive skin patch, known as the sugarBEAT, that is designed to be used by diabetics as a non-invasive continuous glucose monitor.
3. MedShape launches DynaFrame CF deployment system
MedShape announced in a July 11 press release that it has launched its DynaFrame CF Deployment system for implanting the company’s DynaNail TTC Fusion System in tibiotalocalcaneal fusion surgery. The deployment system is made out of carbon-fiber filled polyetheretherketone (PEEK). The launch of the new system also included new DynaNail instrument sets. MedShape’s DynaFrame CF Deployment System has 18 times more rigidity than the system’s original PEEK material. It also has several geometry changes to add more clearance to the distal end of the DynaFrame and its posterior-anterior targeting arm for larger patient anatomies. The changes to the system help reduce issues with drill targeting so that procedures are faster and simpler.